PT874862E - Processo para a 6-o-alquilacao de derivados de eritromicina - Google Patents
Processo para a 6-o-alquilacao de derivados de eritromicinaInfo
- Publication number
- PT874862E PT874862E PT96936904T PT96936904T PT874862E PT 874862 E PT874862 E PT 874862E PT 96936904 T PT96936904 T PT 96936904T PT 96936904 T PT96936904 T PT 96936904T PT 874862 E PT874862 E PT 874862E
- Authority
- PT
- Portugal
- Prior art keywords
- sup
- hydrogen
- hydroxy
- polar aprotic
- eritromycin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/560,752 US5872229A (en) | 1995-11-21 | 1995-11-21 | Process for 6-O-alkylation of erythromycin derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
PT874862E true PT874862E (pt) | 2003-08-29 |
Family
ID=24239215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT96936904T PT874862E (pt) | 1995-11-21 | 1996-10-25 | Processo para a 6-o-alquilacao de derivados de eritromicina |
Country Status (11)
Country | Link |
---|---|
US (2) | US5872229A (pt) |
EP (1) | EP0874862B1 (pt) |
JP (2) | JP2000500488A (pt) |
AT (1) | ATE236919T1 (pt) |
CA (1) | CA2237470C (pt) |
DE (1) | DE69627381T2 (pt) |
DK (1) | DK0874862T3 (pt) |
ES (1) | ES2196184T3 (pt) |
MX (1) | MX9804047A (pt) |
PT (1) | PT874862E (pt) |
WO (1) | WO1997019096A2 (pt) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE29724846U1 (de) | 1996-07-29 | 2004-12-16 | Abbott Laboratories, Abbott Park | Herstellung von kristalliner Form II von Clarithromycin |
US5844105A (en) * | 1996-07-29 | 1998-12-01 | Abbott Laboratories | Preparation of crystal form II of clarithromycin |
US5858986A (en) * | 1996-07-29 | 1999-01-12 | Abbott Laboratories | Crystal form I of clarithromycin |
US5945405A (en) | 1997-01-17 | 1999-08-31 | Abbott Laboratories | Crystal form O of clarithromycin |
US5892008A (en) * | 1997-12-16 | 1999-04-06 | Abbott Laboratories | Process for the preparation of 6-O-methyl erythromycin a using 9-hydroxy erythromycin derivatives |
KR100317907B1 (ko) * | 1998-11-24 | 2001-12-24 | 김 완 주 | 신규한 중간체, 이를 이용한 마크로라이드계 항생제의제조방법 |
US6437106B1 (en) | 1999-06-24 | 2002-08-20 | Abbott Laboratories | Process for preparing 6-o-substituted erythromycin derivatives |
KR100336447B1 (ko) * | 1999-11-24 | 2002-05-15 | 민경윤 | 클라리스로마이신의 개선된 제조방법 |
US6627743B1 (en) | 1999-12-03 | 2003-09-30 | Abbott Laboratories | 6-O-methylerythromycin A crystal form III |
CZ20021999A3 (cs) | 1999-12-16 | 2003-02-12 | Teva Pharmaceutical Industries Ltd. | Způsob přípravy klaritromycinových polymorfních forem a nového polymorfu IV |
PL356645A1 (en) | 2000-01-11 | 2004-06-28 | Teva Pharmaceutical Industries Ltd. | Processes for preparing clarithromycin polymorphs |
US6544555B2 (en) * | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US6565882B2 (en) * | 2000-02-24 | 2003-05-20 | Advancis Pharmaceutical Corp | Antibiotic composition with inhibitor |
AU2578701A (en) * | 2000-02-29 | 2001-09-12 | Teva Pharma | Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same |
AU771825B2 (en) * | 2000-03-15 | 2004-04-01 | Hanmi Pharm. Co., Ltd. | Method of preparing clarithromycin of form II crystals |
KR20000037126A (ko) * | 2000-04-08 | 2000-07-05 | 김용규 | 6-메틸 에리스로마이신 a의 제조방법 |
US20020068078A1 (en) * | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
US6541014B2 (en) * | 2000-10-13 | 2003-04-01 | Advancis Pharmaceutical Corp. | Antiviral product, use and formulation thereof |
US6455680B1 (en) | 2000-12-21 | 2002-09-24 | Abbott Laboratories | Methods utilizing aryl thioimines in synthesis of erythromycin derivatives |
US20020197314A1 (en) * | 2001-02-23 | 2002-12-26 | Rudnic Edward M. | Anti-fungal composition |
TWI246515B (en) | 2001-05-30 | 2006-01-01 | Abbott Lab | An arylation method for the functionalization of O-allyl erythromycin derivatives |
US7435805B2 (en) | 2003-05-30 | 2008-10-14 | Glaxpsmithkline Istrazivacki | O-alkyl macrolide and azalide derivatives and regioselective process for their preparation |
US8313776B2 (en) * | 2003-07-21 | 2012-11-20 | Shionogi Inc. | Antibiotic product, use and formulation thereof |
EP1648418A4 (en) * | 2003-07-21 | 2011-11-16 | Middlebrook Pharmaceuticals Inc | ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION |
AU2004258953B2 (en) * | 2003-07-21 | 2011-02-10 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
EP1653925A1 (en) * | 2003-08-11 | 2006-05-10 | Advancis Pharmaceutical Corporation | Robust pellet |
AU2004264356B2 (en) | 2003-08-12 | 2011-01-27 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
JP5686494B2 (ja) * | 2003-08-29 | 2015-03-18 | シオノギ インコーポレイテッド | 抗生物質製剤、その使用法及び作成方法 |
WO2005027877A1 (en) * | 2003-09-15 | 2005-03-31 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
EP1701705A4 (en) * | 2003-12-24 | 2007-08-08 | Advancis Pharmaceutical Corp | IMPROVED ABSORPTION OF MODIFIED RELEASE DOSAGE FORMS |
JP2008505124A (ja) * | 2004-07-02 | 2008-02-21 | アドバンシス ファーマスーティカル コーポレイション | パルス送達用錠剤 |
US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
US8778924B2 (en) * | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
US8299052B2 (en) | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
US20090054634A1 (en) * | 2007-08-09 | 2009-02-26 | Vinod Kumar Kansal | Process for the preparation of clarithromycin |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3869444A (en) | 1972-10-10 | 1975-03-04 | Abbott Lab | Esters of erythromycin oxime |
FR2473525A1 (fr) | 1980-01-11 | 1981-07-17 | Roussel Uclaf | Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments |
US4331803A (en) | 1980-06-04 | 1982-05-25 | Taisho Pharmaceutical Co., Ltd. | Novel erythromycin compounds |
US4336368A (en) | 1981-04-20 | 1982-06-22 | Pfizer Inc. | 4 Deoxy-4-methylene oleandomycin and derivatives thereof |
JPS5896095A (ja) | 1981-11-30 | 1983-06-07 | Taisho Pharmaceut Co Ltd | 11−o−アルキルエリスロマイシンa誘導体 |
JPS5896097A (ja) | 1981-12-01 | 1983-06-07 | Taisho Pharmaceut Co Ltd | エリスロマイシンb誘導体 |
JPS5896098A (ja) | 1981-12-03 | 1983-06-07 | Taisho Pharmaceut Co Ltd | エリスロマイシンa誘導体 |
US4526889A (en) | 1982-11-15 | 1985-07-02 | Pfizer Inc. | Epimeric azahomoerythromycin A derivative, intermediates and method of use |
JPS60120895A (ja) * | 1983-12-02 | 1985-06-28 | Taisho Pharmaceut Co Ltd | 6−0−メチル−2′−0,ν−ビス(ベンジルオキシカルボニル)−ν−デメチルエリスロマイシンaの製法 |
JPS60214796A (ja) * | 1984-04-06 | 1985-10-28 | Taisho Pharmaceut Co Ltd | 6−0−メチルエリスロマイシン類の製法 |
JPS61103890A (ja) | 1984-10-26 | 1986-05-22 | Taisho Pharmaceut Co Ltd | 6−0−メチルエリスロマイシンa誘導体 |
GB8506380D0 (en) | 1985-03-12 | 1985-04-11 | Beecham Group Plc | Chemical compounds |
DE3668894D1 (en) | 1985-03-12 | 1990-03-15 | Beecham Group Plc | Erythromycin-derivate. |
US4670549A (en) | 1985-03-18 | 1987-06-02 | Taisho Pharmaceutical Co., Ltd. | Method for selective methylation of erythromycin a derivatives |
JPS61229895A (ja) | 1985-04-03 | 1986-10-14 | Nippon Zeon Co Ltd | 保護化デス−n−メチルエリスロマイシン誘導体 |
US4640910A (en) | 1985-11-12 | 1987-02-03 | Abbott Laboratories | Erythromycin A silylated compounds and method of use |
US4833236A (en) | 1986-05-02 | 1989-05-23 | Taisho Pharmaceutical Co., Ltd. | Erythromycin derivatives |
US4740502A (en) | 1986-06-20 | 1988-04-26 | Abbott Laboratories | Semisynthetic erythromycin antibiotics |
DE3782994T2 (de) * | 1986-09-18 | 1993-04-08 | Taisho Pharma Co Ltd | Erythromycin-a-derivate und verfahren zu ihrer herstellung. |
JPH0764867B2 (ja) * | 1986-09-18 | 1995-07-12 | 大正製薬株式会社 | 6−o−メチルエリスロマイシンa誘導体およびその製造方法 |
KR960000434B1 (ko) * | 1986-12-17 | 1996-01-06 | 다이쇼 세이야꾸 가부시끼가이샤 | 에리스로마이신 a유도체 및 그의 제조 방법 |
JP2526951B2 (ja) * | 1986-12-17 | 1996-08-21 | 大正製薬株式会社 | エリスロマイシンa誘導体およびその製造方法 |
JP2751385B2 (ja) | 1988-05-19 | 1998-05-18 | 大正製薬株式会社 | エリスロマイシンaオキシム及びその塩の製造方法 |
JP2782793B2 (ja) * | 1988-06-15 | 1998-08-06 | 大正製薬株式会社 | エリスロマイシンa誘導体およびその製造方法 |
US5302705A (en) | 1989-10-07 | 1994-04-12 | Taisho Pharmaceutical Co., Ltd. | 6-O-methylerythromycin a oxime derivatives |
-
1995
- 1995-11-21 US US08/560,752 patent/US5872229A/en not_active Ceased
-
1996
- 1996-10-25 DE DE69627381T patent/DE69627381T2/de not_active Expired - Fee Related
- 1996-10-25 DK DK96936904T patent/DK0874862T3/da active
- 1996-10-25 JP JP9519720A patent/JP2000500488A/ja not_active Ceased
- 1996-10-25 AT AT96936904T patent/ATE236919T1/de not_active IP Right Cessation
- 1996-10-25 WO PCT/US1996/017017 patent/WO1997019096A2/en active IP Right Grant
- 1996-10-25 EP EP96936904A patent/EP0874862B1/en not_active Expired - Lifetime
- 1996-10-25 CA CA002237470A patent/CA2237470C/en not_active Expired - Fee Related
- 1996-10-25 ES ES96936904T patent/ES2196184T3/es not_active Expired - Lifetime
- 1996-10-25 PT PT96936904T patent/PT874862E/pt unknown
-
1998
- 1998-05-21 MX MX9804047A patent/MX9804047A/es not_active IP Right Cessation
-
2004
- 2004-03-22 US US10/806,089 patent/USRE39383E1/en not_active Expired - Lifetime
-
2007
- 2007-10-24 JP JP2007275992A patent/JP2008110976A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE69627381T2 (de) | 2004-03-25 |
MX9804047A (es) | 1998-09-30 |
JP2000500488A (ja) | 2000-01-18 |
WO1997019096A3 (en) | 1997-07-03 |
US5872229A (en) | 1999-02-16 |
EP0874862B1 (en) | 2003-04-09 |
WO1997019096A2 (en) | 1997-05-29 |
EP0874862A2 (en) | 1998-11-04 |
DK0874862T3 (da) | 2003-07-28 |
ATE236919T1 (de) | 2003-04-15 |
JP2008110976A (ja) | 2008-05-15 |
CA2237470A1 (en) | 1997-05-29 |
ES2196184T3 (es) | 2003-12-16 |
CA2237470C (en) | 2005-01-18 |
USRE39383E1 (en) | 2006-11-07 |
DE69627381D1 (de) | 2003-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT874862E (pt) | Processo para a 6-o-alquilacao de derivados de eritromicina | |
GB9916405D0 (en) | Compounds for mass spectrometry | |
MX221930B (es) | Procedimiento para la obtencion de derivados de trizolintiona. | |
HUT37141A (en) | Process for production of substituted 5,11-dihydro-6h-dibenz /b,e/ azepin-6-ons | |
MY109628A (en) | An improved proces for the preparation of substituted indoline derivatives | |
KR890011904A (ko) | 안드로스타-1,4, -디엔-3,17-디온의 6-메틸렌 유도체 합성방법 | |
PT98519A (pt) | Processo para a preparacao de 4-amino-delta 4,6-esteroides com accao inibidora da 5-alfa-redutase | |
AU683790B2 (en) | Nitric esters from derivatives of 2-(2-6-dihalophenylamino) phenylacetoxyacetic acid and their preparation process | |
KR840005107A (ko) | 피리미디온 및 그의 산부가염의 제조방법 | |
AU5689790A (en) | Reagents for rapid peptide synthesis | |
CA2005596A1 (en) | Preparation of 2-amino-4-fluoropyrimidine derivatives | |
ES2152571T3 (es) | Procedimiento para la preparacion de dioxoazabiciclohexanos. | |
NZ508179A (en) | Process for preparing crystalline salts of amoxycillin | |
BR9405302A (pt) | Processo para a preparação de um composto e o referido composto | |
GR3002989T3 (en) | Process for the production of n-acylated mercapto-alpha-amino acids | |
PT1023272E (pt) | Processo para a producao de alcoxitriazolinonas | |
DK1109782T3 (da) | Fremgangsmåde til fremstilling af N-beskyttede azetidin-2-carboxylsyrer (AzeOH'er) | |
Dalla Croce et al. | 1, 3‐Dipolar cycloaddition of nitrones with α, β‐unsaturated sulfones | |
KR960041287A (ko) | 신규한 디스아조 염료 | |
TW227003B (pt) | ||
GB2322857A (en) | Nitration of aromatic compounds | |
TR200101802T2 (tr) | Benzotiofenkarboksamid türevlerinin hazırlanması için proses | |
HUP0000144A2 (hu) | Eljárás hidroxi-heteroaromás vegyületek aril-aminokká való átalakítására | |
BR0312773A (pt) | Método para produzir um composto altamente puro | |
ES8504186A1 (es) | Un procedimiento para preparar un compuesto de b-lactama monociclica (4r)-sustituida opticamente activa |